Hoth Therapeutics, Inc. (HOTH)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 0.7510 |
| Open | 0.7400 |
| Bid | 0.5810 x 200 |
| Ask | 1.0500 x 200 |
| Day's Range | 0.6559 - 0.8326 |
| 52 Week Range | 0.5800 - 1.7300 |
| Volume | |
| Avg. Volume | 3,739,945 |
| Market Cap | 5.661M |
| Beta (5Y Monthly) | 0.84 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Hoth Stock Up as Lead Drug Heals Skin Toxicities in Cancer Patient
HOTH stock soars on superior efficacy data from the first patient treated with the lead candidate, HT-001, suffering from EGFRI-related skin toxicities.
- Zacks
Hoth Therapeutics (HOTH) Up on Upbeat Alzheimer's Drug Data
Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.
© 2024 Yahoo. All rights reserved.